Professor Andrea Brancale
Projects as PI
1 of 12
- ADC targets from in-silico high throughput screening identification into target validation (01/10/2016 - 21/02/2019)
- ADME/toxicology analyses of lead Schistosoma mansoni histone methyltransferase (HMT) inhibitors (30/06/2018 - 21/02/2019)
- Advanced Therapeutics Wales (01/07/2018 - 21/02/2019)
- All Wales antivirals discovery and development platform (01/01/2016 - 31/03/2019)
- An event to explore Intellectual Property Rights (01/01/2018 - 04/01/2019)
Projects as Co-Investigator
2 of 9
- Computer-aided design, synthesis and evaluation of novel antiviral agents against Norovirus (08/01/2018 - 07/01/2019)
- Derivation of a companion diagnostic for the novel anti-metastatic agent CB1 (01/09/2018 - 30/11/2018)
- Design and synthesis of molecular inhibitors of c-FLIP activity as a therapeutic strategy to target breast cancer stem cells (01/10/2012 - 30/09/2015)
- Design, synthesis and evaluation of novel agents to treat retinal blinding disease, Leber's congenital amaurosis (01/09/2015 - 30/11/2016)
- Developing carbon-monoxide (CO) as synergistic agent to improve anti-VEFG strategy for triple-negative breast cancer (01/10/2015 - 30/09/2018)
